CDKN2A and soft tissue sarcoma: The state of CDKN2A was also employed for the diagnosis of follicular lymphoma as its loss was correlated with poor patient survival [51], and for soft tissue sarcoma where a poor outcome was also observed with CDKN2A deletion [28].